About SUPERFLUID DX, INC.
Superfluid Dx, Inc. is a biotechnology company focused on developing minimally invasive diagnostic technologies, particularly for detecting neurodegenerative diseases like Alzheimer’s at early stages using cf-mRNA. The company aims to revolutionize diagnostics by eliminating the need for invasive procedures.
Development of cf-mRNA-based diagnostic technology for early detection of neurodegenerative diseasesMinimally invasive diagnostic approach eliminating the need for spinal taps and brain scansRepeat assessment of a patient’s disease state over timeApplicable to a wide variety of diseases, with current focus on Alzheimer’s Disease
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to SUPERFLUID DX, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.